Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07116551 · ClinicalTrials.gov registry record · NA
Early Feasibility Study (EFS) of Abbott's Balloon-expandable (BE) TAVI System for the Treatment of Severe, Symptomatic Aortic Stenosis
A NA study of Symptomatic Severe Aortic Stenosis, sponsored by Abbott Medical Devices.
- Active
- Registry status
- NA
- Development phase
- 11
- Enrollment target
- 5
- Study locations
NCT07116551 is a NA study of Symptomatic Severe Aortic Stenosis that is active but no longer recruiting, run by Abbott Medical Devices. The registered enrollment target is 11 participants. The trial reports 5 study locations across 4 states.
The verdict
NCT07116551, a NA study of Symptomatic Severe Aortic Stenosis, is active but no longer recruiting, sponsored by Abbott Medical Devices.
- ACTIVE NOT RECRUITING
- Registry status
- NA
- Development phase
- 11 participants
- Enrollment target
- 5
- Study locations
Study Summary
The purpose of this study is to evaluate the safety and functionality of Abbott's BE TAVI system for the treatment of patients with symptomatic severe aortic valve stenosis.
Conditions Studied
Interventions
- DEVICE Abbott BE TAVI System
Study Locations (5)
New York
- Columbia University Medical Center/New York-Presbyterian - New York
- Montefiore Medical Center - Moses Division - The Bronx
Kansas
- Via Christi Regional Medical Center - Wichita
Minnesota
- Abbott Northwestern Hospital - Minneapolis
Midpyre
- Clinique Pasteur Toulouse - Toulouse
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 11 participants |
| Start Date | 2025-10-30 |
| Est. Completion | 2031-06 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT07116551
The ClinicalTrials.gov registry entry for NCT07116551 describes a study currently listed as active not recruiting, categorized as NA. The registered enrollment target is 11 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Abbott Medical Devices, which has 261 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Symptomatic Severe Aortic Stenosis appearing as the primary indexed condition, and to 1 intervention - of which Abbott BE TAVI System is the first listed.
NCT07116551 reports 5 study locations spanning 4 distinct geographic areas - top geographies include New York, Kansas, Minnesota.
Frequently Asked Questions
What is clinical trial NCT07116551 about?
NCT07116551 is a clinical study titled "Early Feasibility Study (EFS) of Abbott's Balloon-expandable (BE) TAVI System for the Treatment of Severe, Symptomatic Aortic Stenosis". The purpose of this study is to evaluate the safety and functionality of Abbott's BE TAVI system for the treatment of patients with symptomatic severe aortic valve stenosis.
What is the current status of trial NCT07116551?
This trial is currently active not recruiting. It is a NA study. The enrollment target is 11 participants. The study started on 2025-10-30. Estimated completion is 2031-06.
What conditions does trial NCT07116551 study?
This clinical trial studies the following conditions: Symptomatic Severe Aortic Stenosis.
What interventions are being tested in trial NCT07116551?
The interventions under investigation include: Abbott BE TAVI System (DEVICE).
Who is sponsoring clinical trial NCT07116551?
This trial is sponsored by Abbott Medical Devices, which has 261 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT07116551 being conducted?
This trial has 5 study locations across Kansas, Minnesota, New York, Midpyre. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Symptomatic Severe Aortic Stenosis
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.